Gene therapy via adenovirus vector carrying matrix metalloproteinase-3 (MMP-3) in a rat model of liver cirrhosis.
- Author:
So Yeon KIM
1
;
Won Hee HER
;
Jong Soon RYU
;
Jing Sang WANG
;
Si Hyun BAE
;
Jeong Won JANG
;
Chang Wook KIM
;
Mi Sook DONG
;
Seung Kew YOON
Author Information
1. WHO Collaborating Center of Viral Hepatitis, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Liver cirrhosis;
Matrix Metalloproteinase;
Gene Therapy;
Adenoviruses
- MeSH:
Adenoviridae*;
Animals;
Cicatrix;
Collagen;
Dimethylnitrosamine;
Extracellular Matrix;
Fibrosis;
Genetic Therapy*;
Hepatic Stellate Cells;
Hepatocytes;
Humans;
Hydroxyproline;
Injections, Intraperitoneal;
Liver Cirrhosis*;
Liver*;
Matrix Metalloproteinases;
Models, Animal*;
Portal Vein;
Rats*;
Regeneration
- From:Korean Journal of Medicine
2006;71(6):609-619
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Liver cirrhosis is characterized by fibrous scarring and hepatocellular regeneration. Matrix metalloproteinases (MMPs) comprise a family of zinc-dependent enzymes that degrade the extracellular matrix (ECM) components. This study examined whether or not gene delivery of human MMP-3 can attenuate established liver cirrhosis in a rat. METHODS: Rat liver cirrhosis was induced by an intraperitoneal injection of dimethylnitrosamine (DMN) three times a week for 8 weeks. The rats were infected once with either a recombinant adenovirus, AdMMP3.GFP, or a control adenovirus, Ad.GFP, into a portal vein and followed up for 3 weeks. In the rat liver tissues, the collagen content, histopathology and immunohistochemical staining were measured. RESULTS: Liver fibrosis in the DMN induced cirrhotic rat was attenuated along with a diminished hydroxyproline content and increased dried liver weight after the gene delivery of AdMMP3.GFP. In addition, the number of activated hepatic stellate cells was lower whereas the proliferation of hepatocytes, which was confirmed by immunohistochemical staining using anti-proliferating cell nuclear antigen (PCNA) antibody, was observed in the AdMMP3.GFP infected rats, suggesting that human MMP-3 stimulated hepatocyte proliferation. CONCLUSIONS: These results suggest that the gene transfer of human MMP-3 in the liver attenuates established fibrosis and induces hepatocyte proliferation. Therefore, gene therapy using MMP-3 in liver cirrhosis might be a promising therapeutic option in the future.
